Free Trial

Teva Pharmaceutical Industries (TEVA) News Today

Teva Pharmaceutical Industries logo
$13.60 +0.18 (+1.30%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$13.70 +0.09 (+0.70%)
As of 04/17/2025 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Teva Pharmaceutical Industries Limited stock logo
Affinity Asset Advisors LLC Sells 1,000,000 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Affinity Asset Advisors LLC cut its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 41.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,400,000 shares of the company's stock a
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Stock Holdings Increased by Jump Financial LLC
Jump Financial LLC grew its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 128.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 487,103 shares of the company's stock after acquiring an additional 273,493 shares dur
Teva Pharmaceutical Industries Limited stock logo
Franklin Resources Inc. Has $1.03 Million Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Franklin Resources Inc. decreased its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 69.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 46,826 shares of the company's stock after
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded to Hold Rating by StockNews.com
StockNews.com lowered Teva Pharmaceutical Industries from a "buy" rating to a "hold" rating in a research note on Monday.
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries Target of Unusually High Options Trading (NYSE:TEVA)
Teva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) was the recipient of some unusual options trading activity on Monday. Traders bought 86,445 put options on the company. This represents an increase of 136% compared to the typical daily volume of 36,670 put options.
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is Menora Mivtachim Holdings LTD.'s 6th Largest Position
Menora Mivtachim Holdings LTD. lessened its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 1.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 28,381,242 shares of the company's stock after selling 456,797 shares during the peri
Teva Pharmaceutical Industries Limited stock logo
Invesco Ltd. Increases Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Invesco Ltd. boosted its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 6.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,064,529 shares of the company's stock a
Teva Pharmaceutical Industries Limited stock logo
APG Asset Management N.V. Has $1.47 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
APG Asset Management N.V. reduced its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 48.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 68,894 share
Teva Pharmaceutical Industries Limited stock logo
Legal & General Group Plc Sells 1,740,342 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Legal & General Group Plc cut its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 34.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,250,262 shares of the compa
Teva Pharmaceutical Industries Limited stock logo
Sterling Capital Management LLC Sells 237,189 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Sterling Capital Management LLC lowered its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 10.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,071,853 shares
Teva Pharmaceutical Industries Limited stock logo
FIL Ltd Sells 79,243 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
FIL Ltd lessened its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 4.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,528,117 shares of the company's stock after s
Teva Pharmaceutical Industries Limited stock logo
Envestnet Asset Management Inc. Sells 68,650 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Envestnet Asset Management Inc. lessened its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 3.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,038,541 shares of the company's
Teva Pharmaceutical Industries Limited stock logo
Trexquant Investment LP Takes $2.09 Million Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Trexquant Investment LP purchased a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 94,923 shares of the company's stock, valued at approximately $2,092,000. A number of oth
Teva Pharmaceutical Industries Limited stock logo
Renaissance Group LLC Sells 20,167 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Renaissance Group LLC lessened its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 5.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 349,741 shares of the company's stock a
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by Renaissance Technologies LLC
Renaissance Technologies LLC cut its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 14.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,976,218 shares of the company'
Teva Pharmaceutical Industries Limited stock logo
325,921 Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA) Purchased by Resona Asset Management Co. Ltd.
Resona Asset Management Co. Ltd. purchased a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 325,921 shares of the company's stock, valued at approximately $
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Up - Here's Why
Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Up - What's Next?
Teva Pharmaceutical Industries Limited stock logo
ADAR1 Capital Management LLC Has $3.23 Million Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
ADAR1 Capital Management LLC grew its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 35.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 146,671 shares of the company's stock aft
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Bought by Fmr LLC
Fmr LLC lifted its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 30.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 81,983,231 shares of the company's
Teva announces FDA acceptance of sBLA for AJOVY
Teva Pharmaceutical Industries Limited stock logo
Geode Capital Management LLC Has $203.64 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Geode Capital Management LLC grew its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 5.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,281,052 sh
Teva Pharmaceutical Industries Limited stock logo
Zacks Research Issues Optimistic Estimate for TEVA Earnings
Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Analysts at Zacks Research raised their FY2025 earnings per share (EPS) estimates for shares of Teva Pharmaceutical Industries in a note issued to investors on Thursday, April 3rd. Zacks Research analyst R. Department now expects
Zacks Research Has Positive Outlook for TEVA FY2025 Earnings
Teva Pharmaceutical Industries Limited stock logo
Norges Bank Acquires Shares of 1,749,070 Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Norges Bank bought a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,749,070 shares of the company's stock, valued at
Teva Pharmaceutical Industries Limited stock logo
American Century Companies Inc. Buys 19,442 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
American Century Companies Inc. increased its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 9.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 216,523 shares of the company's stock after acquiring an additional
Teva Pharmaceutical Industries Limited stock logo
Zacks Research Issues Positive Forecast for TEVA Earnings
Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Analysts at Zacks Research lifted their Q2 2025 EPS estimates for Teva Pharmaceutical Industries in a research note issued to investors on Thursday, April 3rd. Zacks Research analyst R. Department now anticipates that the company
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Holdings Cut by Cinctive Capital Management LP
Cinctive Capital Management LP cut its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 49.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 117,421 shares of the company's stock afte
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Stock Position Lifted by National Bank of Canada FI
National Bank of Canada FI boosted its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 5,472.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,019,526 shares of
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries (NYSE:TEVA) Upgraded to Buy at StockNews.com
StockNews.com upgraded shares of Teva Pharmaceutical Industries from a "hold" rating to a "buy" rating in a research report on Friday.
Teva Pharmaceutical Industries Limited stock logo
B. Metzler seel. Sohn & Co. AG Buys 50,995 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
B. Metzler seel. Sohn & Co. AG grew its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 202.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 76,244 shares of the
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Short Interest Up 25.1% in March
Teva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) saw a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 34,800,000 shares, a growth of 25.1% from the February 28th total of 27,810,000 shares. Based on an average daily trading volume, of 12,260,000 shares, the days-to-cover ratio is presently 2.8 days. Currently, 3.1% of the shares of the company are short sold.
Teva Pharmaceutical Industries Limited stock logo
Pictet Asset Management Holding SA Buys 52,938 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Pictet Asset Management Holding SA lifted its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 9.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 598,487 shares of th
Teva Pharmaceutical Industries Limited stock logo
Schroder Investment Management Group Increases Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Schroder Investment Management Group lifted its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 145.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2
Teva Pharmaceutical Industries Limited stock logo
DnB Asset Management AS Boosts Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
DnB Asset Management AS lifted its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 13.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 184,940 sha
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by UniSuper Management Pty Ltd
UniSuper Management Pty Ltd lessened its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 93.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 21,700 shares of the company's stock after s
Teva Pharmaceutical Industries Limited stock logo
Korea Investment CORP Purchases 159,899 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Korea Investment CORP grew its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 72.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 381,955 shares of the company's stock after purchasing an additional 15
Teva Pharmaceutical Industries Limited stock logo
Teva Pharmaceutical Industries (NYSE:TEVA) Shares Up 2.5% - Still a Buy?
Teva Pharmaceutical Industries (NYSE:TEVA) Shares Up 2.5% - Here's What Happened
Get Teva Pharmaceutical Industries News Delivered to You Automatically

Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter.

TEVA Media Mentions By Week

TEVA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TEVA
News Sentiment

1.23

0.49

Average
Medical
News Sentiment

TEVA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TEVA Articles
This Week

20

11

TEVA Articles
Average Week

Get Teva Pharmaceutical Industries News Delivered to You Automatically

Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:TEVA) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners